BioAsia 2026 in Hyderabad: Telangana's Life Sciences Hub
Analysis based on 10 articles · First reported Feb 16, 2026 · Last updated Feb 18, 2026
The BioAsia 2026 conference highlights India===Telangana's growing prominence as a global life sciences hub, attracting significant investments and fostering innovation. This event is expected to positively impact the biotechnology, pharmaceuticals, and healthcare sectors by driving collaborations and technological advancements.
The 23rd edition of BioAsia 2026, Asia's leading life sciences and health tech forum, commenced in Hyderabad, India===Telangana. The event, themed 'TechBio Unleashed: AI, Automation, and the Biology Revolution,' brought together global stakeholders from biotechnology, pharmaceuticals, Medtech, digital health, research, investment, and policy sectors. Chief Minister Revanth Reddy highlighted India===Telangana's policy initiatives, including the India===Telangana Next-Gen Life Sciences Policy, expansion of Genome Valley, and significant investments of over Rs.73,000 crore in the life sciences sector over the last two years. The state aims to attract US$25 billion in investments by 2030 and create five lakh new jobs. Investment announcements were made by Sanofi===Opella, Japfa===Vaksindo Animal Health Private Limited (a division of Japfa), Tredence, and Rx Propellant. Professor Bruce Levine from the University of Pennsylvania received the Genome Valley Excellence Award. The conference underscores India===Telangana's ambition to become a top global life sciences cluster.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard